The analysis of the OS of NSCLC patients showed a worse prognosis in cases with higher POSTN expression in CAFs compared to patients with low expression of the protein, indicating the influence of this glycoprotein in cancer development. This evidence concerns the gene POSTN and non-small cell lung carcinoma.